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Strengths and limitations of this study
 ► This study systematically reviews the published 
evidence for dermoscopy use by primary care phy-
sicians in primary care settings, including studies 
of acceptability and cost-effectiveness, as well as 
diagnostic accuracy studies.
 ► The use of a broad search strategy across multiple 
databases enabled us to identify 23 studies whose 
findings examine dermoscopy use in primary care 
clinical practice.
 ► The included studies were of varying quality.
 ► Due to the heterogeneity of the included papers, we 
were not able to undertake any meta-analysis; in-
stead, we performed a narrative synthesis.
AbStrACt
Objective Most skin lesions first present in primary care, 
where distinguishing rare melanomas from benign lesions 
can be challenging. Dermoscopy improves diagnostic 
accuracy among specialists and is promoted for use by 
primary care physicians (PCPs). However, when used by 
untrained clinicians, accuracy may be no better than visual 
inspection. This study aimed to undertake a systematic 
review of literature reporting use of dermoscopy to triage 
suspicious skin lesions in primary care settings, and 
challenges for implementation.
Design A systematic literature review and narrative 
synthesis.
Data sources We searched MEDLINE, Cochrane Central, 
EMBASE, Cumulative Index to Nursing and Allied Health 
Literature, and SCOPUS bibliographic databases from 1 
January 1990 to 31 December 2017, without language 
restrictions.
Inclusion criteria Studies including assessment of 
dermoscopy accuracy, acceptability to patients and 
PCPs, training requirements, and cost-effectiveness of 
dermoscopy modes in primary care, including trials, 
diagnostic accuracy and acceptability studies.
results 23 studies met the review criteria, representing 
49 769 lesions and 3708 PCPs, all from high-income 
countries. There was a paucity of studies set truly in 
primary care and the outcomes measured were diverse. 
The heterogeneity therefore made meta-analysis 
unfeasible; the data were synthesised through narrative 
review. Dermoscopy, with appropriate training, was 
associated with improved diagnostic accuracy for 
melanoma and benign lesions, and reduced unnecessary 
excisions and referrals. Teledermoscopy-based referral 
systems improved triage accuracy. Only three studies 
examined cost-effectiveness; hence, there was insufficient 
evidence to draw conclusions. Costs, training and time 
requirements were considered important implementation 
barriers. Patient satisfaction was seldom assessed. 
Computer-aided dermoscopy and other technological 
advances have not yet been tested in primary care.
Conclusions Dermoscopy could help PCPs triage 
suspicious lesions for biopsy, urgent referral or 
reassurance. However, it will be important to establish 
further evidence on minimum training requirements to 
reach competence, as well as the cost-effectiveness 
and patient acceptability of implementing dermoscopy in 
primary care.
trial registration number CRD42018091395.
IntrODuCtIOn
Worldwide malignant melanoma is the 15th 
most common cancer.1 Melanoma has one of 
the fastest rising incidence rates of any cancer, 
and among white populations incidence has 
quadrupled over the last 30 years. In the 
UK this is projected to rise by a further 7% 
between 2014 and 2035, reflecting increasing 
exposure to the main risk factor, ultraviolet 
radiation.2 There were nearly 300 000 new 
cases of melanoma worldwide in 2018.1
Primary care (the first point of contact for 
patients in the healthcare system, usually 
community-based) can play an important 
role in improving outcomes for patients with 
melanoma. More accurate triage of suspicious 
pigmented skin lesions could lead to more 
prompt diagnosis of melanoma at earlier 
stages and improved outcomes, and reduce 
unnecessary biopsies or referrals. Most 
people diagnosed with cancer first present in 
primary care,3 where primary care physicians 
(PCPs) need to distinguish rare melanomas 
from common benign lesions using clinical 
history taking and visual inspection, aided 
by checklists such as the 7-point checklist as 
recommended in the 2015 National Institute 
for Health and Care Excellence guidelines 
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for suspected cancer.4 Various technologies may also 
have a role in assisting triage of suspicious skin lesions, 
including mobile phone applications,5 reflectance 
confocal microscopy,6 optical coherence tomography,7 
computer-aided diagnosis,8 high-frequency ultrasound9 
and dermoscopy.10
Dermoscopy (also referred to as dermatoscopy or 
epiluminescence microscopy) is a non-invasive tech-
nique using a hand-held magnifier and incident light, 
which may be polarised to reduce reflection, to reveal 
subsurface structures. Dermoscopy performed by trained 
specialists is more sensitive and specific in classifying 
skin lesions than clinical examination with the naked 
eye alone.4 11 Dermatologists and some international 
guidelines recommend PCPs use dermoscopy12; however, 
when used by untrained or less experienced clinicians, 
accuracy can be no better than inspection alone,13 and 
there is a danger of increased excisions, over-referral or 
false reassurance. It takes time to train clinicians to use 
dermoscopy, and PCP training dropout rates have been 
shown to be high.14 15 For these reasons dermoscopy is 
not currently recommended for use by PCPs in the UK,4 
although it is used routinely by PCPs in Australia,16 which 
has the highest incidence of melanoma worldwide. Some 
digital dermoscopy devices exist, a few of which incor-
porate computer-aided diagnosis, but they are expen-
sive, and while showing better sensitivity even in expert 
hands many have lower specificity than clinicians alone.17 
However, recent research suggests computer-aided diag-
nostic tools have the potential to exceed the diagnostic 
performance of dermatologists.18
A Cochrane review of dermoscopy has recently been 
published and examines the diagnostic accuracy of 
dermoscopy, with and without visual inspection, for the 
detection of cutaneous invasive melanoma and intraepi-
dermal melanocytic variants in adults.19 Our systematic 
review has a broader aim, focusing on the first presenta-
tion of suspicious skin lesions in primary care and whether 
dermoscopy and dermoscopy-related technologies, with 
suitable training, can be used accurately and effectively 
to triage suspicious skin lesions at this point in the health-
care pathway. We considered various types of dermos-
copy technologies, including hand-held dermoscopy, 
computer-aided/digital dermoscopy devices and novel 
teledermoscopy approaches (ie, referral using electronic 
dermoscopy images or video). In addition to data on the 
diagnostic accuracy of dermoscopy, we looked for data on 
the practical challenges to implementing dermoscopy in 
primary care, including utility, acceptability to patients 
and PCPs, training requirements, and cost-effectiveness.
MethODS
This systematic review was conducted in accordance with 
the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) guidelines,20 and the protocol 
was registered with PROSPERO prior to conducting 
the review.21 All aspects of the protocol were reviewed 
by senior faculty from the CanTest Collaborative ( www. 
cantest. org).
We searched the MEDLINE, EMBASE, Cochrane 
Central, Cumulative Index to Nursing and Allied Health 
Literature, and SCOPUS databases using keywords 
related to dermoscopy, melanoma and primary care, 
without language restrictions, from 1 January 1990 to 31 
December 2017. We also manually searched the reference 
lists of included studies. We included all types of study 
design as we anticipated that there would be few relevant 
randomised controlled trials (RCTs) or diagnostic accu-
racy studies performed in primary care, and we aimed 
to find additional qualitative evidence on barriers to the 
use of dermoscopy which may be found in non-RCT study 
designs. We chose to start the search from 1990 as this was 
when the earliest dermoscopy-related research emerged. 
We considered published evidence from any interna-
tional healthcare system and whether it could be inter-
preted and applied to primary care settings, including 
the extent to which data collected from specialist clinic 
settings could be applied to the lower-prevalence primary 
care population.
We included all studies which provide evidence around 
test accuracy, utility, acceptability to patients and PCPs, 
training requirements, and cost-effectiveness of dermos-
copy modes in primary care, including trials, diagnostic 
accuracy and acceptability studies. As our interest was 
in the use of dermoscopy by generalist clinicians, we 
included all studies reporting PCP use of dermoscopy; 
studies of secondary care physicians who were not trained 
in dermoscopy were assessed for the applicability of their 
study to answer the research question. We excluded 
studies that were based in any clinical setting other than 
at the first assessment of suspicious skin lesions, and any 
studies that were not considered primary studies.
Following duplicate removal, one author (OJ) screened 
titles and abstracts to identify studies which fitted the 
inclusion criteria. Of the titles and abstracts 10% were 
checked by two other authors (LJ and SH), and interas-
sessor reliability was excellent, with disagreement for only 
1 out of the 100 papers checked. Any disagreements were 
discussed by the core research team (OJ, LJ, SH, FMW) 
and a consensus reached. At least two reviewers (OJ, 
LJ, SH, MvM, FMW) independently assessed each full-
text article for the possibility of inclusion in the review. 
Any disagreements were resolved by consensus-based 
discussion.
Data extraction was undertaken by two reviewers inde-
pendently (OJ, LJ, FMW) and summarised using descrip-
tive tables, discussion and consensus. We chose to extract 
only reported outcomes from the included papers, 
without calculating further quantitative measures of diag-
nostic accuracy from their data, unless already reported. 
Due to the heterogeneity of the included papers, we were 
not able to undertake any meta-analysis; instead, we chose 
to perform a narrative synthesis.
Risk-of-bias assessment was undertaken for each full-
text paper by two independent researchers (OJ, LJ) using 
3Jones OT, et al. BMJ Open 2019;9:e027529. doi:10.1136/bmjopen-2018-027529
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Figure 1 PRISMA flow diagram for the studies included in 
the review. CINAHL, Cumulative Index to Nursing and Allied 
Health Literature; PRISMA, Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses.
the Joanna Briggs Institute (JBI) critical appraisal tools.22 
These tools incorporate various critical assessments for 
different study designs, including patient selection, rando-
misation, data collection and analysis. As assessments for 
different study designs had varying denominators, the 
score was converted to a percentage and classified as high, 
medium and low risk to aid clarity of presentation and 
interpretation. Although the studies demonstrated a wide 
range in quality, no studies were excluded based on their 
risk-of-bias assessment. Full details of our review ques-
tion, search strategy, inclusion/exclusion criteria, meth-
odology for data extraction, risk-of-bias assessment and 
outcomes extraction are described in online supplemen-
tary appendices 1 and 2, as well as a full list of excluded 
studies (online supplementary appendix 3).
Patient and public involvement
Our long-standing collaborator, Mrs Margaret Johnson, is 
a patient advocate. She commented regularly on the study 
from its conception, including aspects of the research 
question, outcome measures and study design. There 
was no patient recruitment required for this study. The 
results will be disseminated to patient advocates, groups 
and relevant charities.
reSultS
Figure 1 shows the study PRISMA diagram. There were 
837 studies identified, of which 349 were duplicates. Nine-
ty-five articles underwent full-text review and 23 met the 
inclusion criteria.14 23–44 These 23 articles reported data 
relating to 49 769 lesions and 3708 PCPs.
Table 1 provides a summary of the study characteris-
tics for included studies. We included three RCTs, two 
sequential intervention trials (SIT), nine diagnostic 
accuracy studies, two cohort studies, two case series, 
one case–control study and four PCP surveys. Table 1 
also visually summarises the practitioner and patient 
populations reported in the studies and highlights the 
paucity of studies reporting PCPs using dermoscopy with 
primary care patients (5 out of 16). Studies of teleder-
moscopy-based referral systems were more frequently set 
in primary care, with six out of seven studies involving 
primary care clinicians and primary care patients. Overall, 
16 of the 23 papers reported studies of PCPs, but only 11 
papers reported studies involving primary care patients.
Table 2 summarises the outcome measures of each 
included study, grouped into accuracy and reliability 
outcomes and implementation outcomes, and shows the 
heterogeneous nature of the reported outcomes. The 
accuracy and reliability outcomes were diverse; 12 papers 
reported sensitivity and specificity, 8 reported diagnostic 
accuracy or area under the curve, 5 reported positive 
and negative predictive values, 14 reported the propor-
tion of correct decisions, 4 reported the number needed 
to excise, and 5 reported the biopsy rate. The imple-
mentation outcomes were less numerous but also quite 
diverse: 4 papers reported on PCP opinions, 3 performed 
cost-effective analyses, 2 looked at response times for 
teledermoscopy services, 2 looked at image quality for 
teledermoscopy, and 1 assessed patient satisfaction.
Risk-of-bias outcomes from the JBI critical appraisal 
tools are included in table 2, demonstrating a wide range 
in quality across the studies. No studies were excluded 
based on the risk-of-bias assessment.
Tables 3 summarises the diagnostic accuracy results, 
with the studies grouped into RCTs and SITs, non-RCT 
diagnostic accuracy studies, and survey studies. Among 
the RCTs and SITs, Argenziano et al,23 Koelink et al,24 
Rosendahl et al43 and Menzies et al14 found that dermos-
copy reduced the number needed to excise to diagnose 
a melanoma. Ferrándiz et al26 evaluated the impact of 
adding dermoscopic images to the standard telederma-
tology referral system and found that it improved accu-
racy and confidence in diagnosing skin lesions.
Most of the studies were non-RCT diagnostic accuracy 
studies. These showed increased diagnostic accuracy with 
the use of dermoscopy in primary care28 33 35 43 44 or in 
teledermoscopy-based referral systems.34–37 Some studies 
suggested this was due to improved ability to identify 
benign lesions when using a dermatoscope.27 31 32 44 All 
studies that assessed the effect of training found that it 
improved diagnostic accuracy compared with minimal 
or no training.25 29–33 44 There was evidence that use of 
dermoscopy without training displayed similar diagnostic 
accuracy to naked-eye examination.33 Menzies et al29 
showed that a dermoscopy-related technology, SolarScan, 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































had higher sensitivity than PCPs, although this was a 
non-significant finding.
Table 4 summarises findings from the studies which 
investigated barriers and facilitators to implementing 
dermoscopy in primary care. Training requirements, cost 
of equipment and the time taken to perform dermos-
copy were the most important barriers identified from 
the studies. However, for each barrier there were some 
papers that described it as a facilitator instead. Three 
papers performed cost-effective analyses of dermoscopy24 
and teledermoscopy,26 41 and none found a significant 
cost-effective advantage. The main facilitators identified 
to the use of dermoscopy in primary care were reduced 
referrals, early detection of melanoma, and reduced 
patient and physician anxiety.
Patient and PCP attitudes and acceptance of dermoscopy
Several papers assessed PCP attitudes to dermoscopy 
through questionnaires. Stratton and Loescher42 found 
that nurse practitioners in the USA did not widely use 
dermatoscopes; however, they thought that dermoscopy 
would have a positive impact and would be willing to use 
mobile teledermoscopy if they received training. Morris 
et al39 40 found that dermoscopy use among US physicians 
and doctors of osteopathic medicine was associated with 
seeing higher numbers of patients and with higher confi-
dence in diagnosing skin lesions. Chappuis et al38 found 
that dermoscopy use among French general practitioners 
(GPs) was associated with being older and male, and that 
only 8% of respondents had access to a dermatoscope. 
Livingstone and Solomon’s41 survey was the only one that 
assessed patient acceptability; they reported that 97% of 
patients from one general practice in Greater London 




Only a small number of studies have examined the 
use of dermoscopy or dermoscopy-related technolo-
gies in the primary care setting. These studies were all 
set in Europe, the USA and Australia, and due to their 
heterogeneous nature we were not able to synthesise the 
findings. Nevertheless, our review found that, with appro-
priate training, dermoscopy in primary care is more accu-
rate than naked-eye examination, with improvements in 
sensitivity and specificity and number needed to excise. 
Furthermore, there was some evidence that teleder-
moscopy-based referral systems improve triage accuracy 
compared with paper-based or macroscopic image-based 
referral systems. The limited evidence did not show a 
significant cost-effectiveness benefit for either dermos-
copy or teledermoscopy, although dermoscopy appears to 
lead to a reduction in unnecessary referrals and excisions. 
Importantly, the review also suggests that PCPs are recep-
tive to incorporating dermoscopy into their routine prac-
tice, although they recognised ongoing implementation 








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































barriers, particularly around training, time requirements 
and technology costs.
Comparison with other studies
Our review suggests that dermoscopy in primary care is 
more accurate than naked-eye examination, supporting 
the findings from a previous review of dermoscopy 
for melanoma detection specifically in primary care 
published in 2012.45 A recently published Cochrane 
review of dermoscopy for the diagnosis of melanoma has 
also concluded that, although data to support dermos-
copy use in primary care are limited, ‘it may assist in 
triaging suspicious lesions for urgent referral when 
employed by suitably trained clinicians’.19 Our review 
also suggests that training PCPs in dermoscopy improves 
diagnostic accuracy. Again, this finding is supported by 
the recent Cochrane review which also suggests that 
‘formal algorithms may be of most use for dermoscopy 
training purposes and for less expert observers, however 
reliable data comparing approaches using dermoscopy 
in-person are lacking’.19 Previous reviews have shown that 
using dermoscopy without training was no more accu-
rate than naked-eye examination alone.13 19 However, we 
were not able to identify the optimal length of training 
needed to train PCPs to use dermoscopy accurately, 
although studies of the effect of training on dermatolo-
gist diagnostic performance have shown improvement 
after between 2 days (6 hours of training per day)46 and 
10 weeks (comprising 6 workshops of 4–6 hours).47 PCPs 
are likely to need short training courses, preferably with 
regular updates, as one of the few RCTs examining the 
impact of dermoscopy on the management of pigmented 
lesions in primary care reported a high dropout rate of 
GPs from the 20 hours of online trainingrequired for that 
study.14
It is important to note that the performance of dermos-
copy in specialist clinics is not directly translatable as 
evidence for the performance of dermoscopy in primary 
care settings. A spectrum effect or spectrum bias is often 
observed when tests developed in one population are then 
used on another population. For example, the secondary 
care population is a referred population and has a higher 
prevalence of the condition being tested than primary 
care populations. This means that a diagnostic test, such 
as dermoscopy, will perform differently in the primary 
care population with the lower prevalence of the condi-
tion, compared with the secondary care population.48 
The direction of effect is not consistent across tests and 
conditions; hence, to establish the performance of tests 
among the non-referred population in primary care, they 
need to be evaluated in a primary care population. This 
review has therefore aimed to examine existing evidence 
for dermoscopy use in primary care settings.
Our review suggests that a range of PCPs, including 
nurse practitioners in the USA, and PCPs in the USA 
and France, hold positive views about incorporating 
dermoscopy into their routine practice. Evidence from 
Australia supports these views and demonstrates that 
13Jones OT, et al. BMJ Open 2019;9:e027529. doi:10.1136/bmjopen-2018-027529
Open access
Table 4 Barriers and facilitators to implementation of dermoscopy and teledermoscopy
Aspect Quoted as barrier in: Type of study Quoted as facilitator in: Type of study
Training requirements Chappuis et al38 Survey Pagnanelli et al30 DA study
Morris et al40 Survey
van der Heijden et al37 Cohort study
Cost* Chappuis et al38 Survey Koelink et al24* RCT
Morris et al39 Survey Rosendahl et al25 Cohort study
Moreno-Ramirez et al36 DA study Ferrándiz et al26* RCT
Livingstone and Solomon41* Case series
Time consumption Chappuis et al38 Survey Börve et al34 Case–control
Moreno-Ramirez et al36 DA study
van der Heijden et al37 Cohort study
Reimbursement for offering 
dermoscopy services (in USA)
Morris et al39 Survey     
Equipment issues van der Heijden et al37 Cohort study Börve et al34 Case–control
Moreno-Ramirez et al36 DA study
Reduced referrals     Chappuis et al38 Survey
Koelink et al24 RCT
Börve et al34 DA study
Moreno-Ramirez et al36 DA study
Early detection of melanoma     Chappuis et al38 Survey
Reduced patient anxiety     Chappuis et al38 Survey
Reduced physician anxiety     Chappuis et al38 Survey
Moreno-Ramirez et al36 DA study
Menzies et al14 DA study
*Based on studies where a cost-effective analysis was undertaken.
DA, diagnostic accuracy; RCT, randomised controlled trial.
a wide range of PCPs are able to incorporate dermos-
copy into their routine clinical practice.16 Only a small 
number of cost-effectiveness studies met our review 
criteria. They all assessed dermoscopy and teledermos-
copy from a healthcare perspective, and only reported 
on short-term costs resulting from dermoscopy or 
non-dermoscopy approaches. None reported a signif-
icant cost-effectiveness benefit for dermoscopy24 or 
teledermoscopy,26 in the primary care setting, although 
they recommended the technologies as potentially 
useful tools. An English RCT of another diagnostic aid 
(MoleMate, incorporating SIAscopy) in primary care49 
also reported equivocal findings on cost-effectiveness, 
as the device, similar in accuracy to systematic applica-
tion of the 7-point checklist, resulted in increased refer-
rals from primary care.49 50
Interestingly, no papers reporting the use of dermos-
copy smartphone applications (‘apps’) for automated 
diagnosis of melanoma or skin cancers in the primary 
care setting met the review inclusion criteria. Kassianos 
et al51 reviewed 39 smartphone applications and found 
little evidence of clinical or research-based input into the 
design or evaluation of these apps. A recent editorial in 
The Lancet Oncology supported this finding,52 and urged 
caution with early adoption of new technologies that 
are often poorly designed and untested, stressing the 
need to ensure that these technologies are appropriate, 
cost-effective and do not compromise patient safety. 
Recent studies have tested the application of artificial 
intelligence, neural networks and machine learning to 
the diagnosis of skin lesions; however, they have not yet 
been assessed in primary care settings.
Strengths, limitations and future research
Our review examines the evidence for dermoscopy 
use in the primary care setting. It builds on the recent 
Cochrane review which explicitly reviewed evidence 
only about diagnostic accuracy of dermoscopy, with 
and without naked-eye examination, and describes 
this in specialist and generalist settings.19 We therefore 
included studies with a range of methods, surveys and 
qualitative studies, as well as RCTs and diagnostic accu-
racy studies, but still only identified a relatively small 
number of publications. Unfortunately, we were unable 
to perform a meta-analysis due to the heterogeneity in 
study designs, settings, populations and outcomes. All 
the studies are from high-income countries and there-
fore may be less generalisable to other countries with 
different healthcare systems.
COnCluSIOnS
Despite the limited evidence, this review provides 
moderate support for the use of dermoscopy in primary 
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care, with the weight of the available evidence pointing 
to a benefit in diagnostic accuracy for managing suspi-
cious skin lesions. Dermoscopy is acceptable to PCPs, so 
it could help them triage suspicious lesions for urgent 
referral or reassurance. However, it will be important 
to establish further evidence on minimum for training 
to reach competence, as well as the cost-effectiveness 
and patient acceptability of implementing dermoscopy 
in primary care.
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